AusPAR: Eltrombopag

Australian Public Assessment Report

AusPAR

AusPAR Eltrombopag [PDF, 713.52 KB]

AusPAR Eltrombopag [Word, 831.43 KB]

Attachment: Product Information: Eltrombopag [PDF, 359.06 KB]

Attachment: Product Information: Eltrombopag [Word, 159.62 KB]

Attachment: Extract from Clinical Evaluation Report: Eltrombopag [PDF, 1.02 MB]

Attachment: Extract from Clinical Evaluation Report: Eltrombopag [Word, 1.38 MB]

Device/Product Name

Revolade

Active ingredients

Eltrombopag

AusPAR Date

30 March 2016

Published

12 April 2016

Submission Number

PM-2014-04303-1-4

Submission Type

Extension of indications

Decision

Approved